How current maintenance therapy is changing in ovarian cancer and what’s next

Description

Listen to international experts as they discuss state of the art of maintenance in first and second line, criteria for choosing treatment, and unmet needs.

Recorded on October 12, 2023

Attended previous IGCS webinars? If you have attended IGCS webinars in the past, you may already have an IGCS account and creating a new account is not required. If unsure of your login information, you may reset your information by selecting "Forgot Password" at login or contact education@igcs.org.

If you have questions or need assistance, contact education@igcs.org.

Faculty Information

	Robert Coleman, MD, FACOG, FACS Chief Medical Officer Vaniam Group USA
	Mansoor Mirza, MD Chief Oncologist, Rigshospitalet Medical Director, NSGO-CTU Denmark
	Tashanna Myers, MD Division Chief, Gynecologic Oncology, Department of Obstetrics-Gynecology Medical Director, Gynecologic Oncology, Baystate Health Associate professor, Department of Ob/GYN UMass Chan-Baystate Vice Chair, Academic Affairs, Department of OB/GYN USA
	Domenica "Ketta" Lorusso, MD, PhD Associate Professor of Obstetrics and Gynecology Fondazione Policlinico Universitario A Gemelli Italy

Supported in part by

Summary

Availability:

On-Demand

Cost:

FREE

Create Account

Recommended

Phase III MIRASOL (GOG 3045/ENGOT-ov55) Study Results

FREE

New Options in Platinum Resistant Ovarian Cancer

FREE

An Evolving Frontier: Endometrial Cancer Treatment

FREE

Immunotherapy and its impact on overall survival in patients with recurrent endometrial cancer

FREE

Treatment Options for Platinum Resistant Ovarian Cancer

FREE

Changing the standard of care in 2nd line recurrent cervical cancer

FREE

Personalized Management of Advanced or Recurrent Endometrial Cancers: Navigating pMMR, dMMR Subtypes, or Molecular Classifications

FREE

Moving Towards Personalized Therapy in Endometrial Cancer

FREE

IGCS 2024 Cervical Master Sessions: Moving Forwards

FREE

Phase II PICCOLO Trial Results

Results of Phase II PICCOLO Trial are available. Dr. Angeles Alvarez Secord, PI of PICCOLO Trial, and Dr. Wendel Naumann discuss results of MIRV in Recurrent Platinum-Sensitive Ovarian Cancer with High Folate Receptor-Alpha Expression.

FREE